SCHEMBL29598792

SCHEMBL29598792

Oc1cccc2ncc3ccccc3c12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
GPR3 P46089 1/20 0.57
CYP1A2 P05177 3/20 0.47
MAPKAPK2 P49137 1/20 0.43
ERN1 O75460 1/20 0.42
MAPT P10636 3/20 0.42
HPGD P15428 3/20 0.42
ALOX15 P16050 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
TSHR P16473 2/20 0.42
APP P05067 1/20 0.42
THRB P10828 1/20 0.42
CASP1 P29466 1/20 0.42
SNCA P37840 1/20 0.42
RECQL P46063 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 2/20 0.41
GAA P10253 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL241588 1.00 KDM4E (0.57) KDM4EGPR3CYP1A2MAPKAPK2ERN1
Hydrochloric Acid SCHEMBL28873693 0.98 KDM4E (0.55) KDM4EGPR3CYP1A2MAPKAPK2ERN1
SCHEMBL28342409 0.86 KDM4E (0.50) KDM4EGPR3CYP1A2MAPKAPK2ERN1
SCHEMBL30857515 0.81 KDM4E (0.61) KDM4EGPR3CYP1A2MAPTHPGD
SCHEMBL22653576 0.80 KDM4E (0.50) KDM4EGPR3CYP1A2ERN1MAPT
SCHEMBL9038627 0.79 KDM4E (0.59) KDM4EGPR3CYP1A2MAPTHPGD
SCHEMBL27973182 0.79 GPR3 (0.64) KDM4EGPR3CYP1A2MAPTHPGD
SCHEMBL5379235 0.79 KDM4E (0.48) KDM4EGPR3ERN1MAPTHPGD
SCHEMBL9935648 0.79 KDM4E (0.53) KDM4EGPR3CYP1A2HPGDTDP1
SCHEMBL10025808 0.78 GPR3 (0.68) KDM4EGPR3CYP1A2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119285545-A Method for constructing 6 (5H) -phenanthridinone compound by utilizing natural light induced carbonylation reaction 桂林理工大学 2025-01-10 CN claimed
CN-114729052-B Anti-KIR 3DL3 antibodies and uses thereof 丹娜法伯癌症研究院 2026-05-22 CN disclosed
WO-2025120516-A1 COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2025-06-12 WO disclosed
CN-119451692-A Mass spectrometry method for cancer diagnosis AOA DX公司 2025-02-14 CN disclosed
CN-112153977-B KIR3DL3, anti-HHLA 2 antibodies as HHLA receptor and uses thereof 丹娜法伯癌症研究院 2025-01-10 CN disclosed
CN-119285545-A Method for constructing 6 (5H) -phenanthridinone compound by utilizing natural light induced carbonylation reaction 桂林理工大学 2025-01-10 CN disclosed
CN-119285545-A Method for constructing 6 (5H) -phenanthridinone compound by utilizing natural light induced carbonylation reaction 桂林理工大学 2025-01-10 CN disclosed
CN-119285545-A Method for constructing 6 (5H) -phenanthridinone compound by utilizing natural light induced carbonylation reaction 桂林理工大学 2025-01-10 CN disclosed
CN-118662499-A Compositions and methods for treating cancer and autoimmune diseases 雪松-西奈医学中心 2024-09-20 CN disclosed
CN-118510797-A Binding proteins recognizing HPV 16E 7 antigen and uses thereof 帝斯肯医疗公司 2024-08-16 CN disclosed
WO-2023228005-A1 COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-11-30 WO disclosed
CN-117120086-A Compositions and methods for cancer diagnosis AOA DX公司 2023-11-24 CN disclosed
WO-2023139526-A1 COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-07-27 WO disclosed
CN-116354882-A Pure organic room temperature phosphorescent material with phenanthridinone structure, and preparation method and application thereof 香港科技大学深圳研究院 2023-06-30 CN disclosed
EP-4168417-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND Idemitsu Kosan Co., Ltd (JP) 2023-04-26 EP disclosed
CN-115996953-A anti-VSIG 4 compositions and methods for modulating inflammatory phenotypes of myeloid cells and uses thereof 维西欧制药公司 2023-04-21 CN disclosed
WO-2023042574-A1 COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2023-03-23 WO disclosed
CN-109689062-B Methods of treating PTEN-deficient epithelial cancers using a combination of anti-PI 3K β and anti-immune checkpoint agents 丹娜法伯癌症研究院 2023-02-17 CN disclosed
WO-2022107064-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2022-05-27 WO disclosed
WO-2022074616-A1 HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2022-04-14 WO disclosed